Insulclock will attend to ATTD to be held in Madrid on February 19th to 22nd. Insulclock will have a both at the Congress fairground (Trade Fair 39) to present its technology for patients with diabetes. Furthermore, Insulclock will show its last R & D project: InsulWatch.
Insulclock will pitch several times during the Congress explaining and showing the Insulclock System formed by the web platform ENDO, the device for tracking the use of disposable insulin pens, the app and the new InsulWatch.
It will also present to the audience several posters about clinical trials that are being developed in different health institutions in Spain.